NEM | ||
|---|---|---|
OUTLOOK RATING 1..100 | 72 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 62 Fair valued | |
PROFIT vs RISK RATING 1..100 | 55 | |
SMR RATING 1..100 | 38 | |
PRICE GROWTH RATING 1..100 | 53 | |
P/E GROWTH RATING 1..100 | 45 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| FGM | NEM | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 4 days ago 72% | 4 days ago 69% |
| Momentum ODDS (%) | 4 days ago 77% | 4 days ago 74% |
| MACD ODDS (%) | 4 days ago 83% | 4 days ago 71% |
| TrendWeek ODDS (%) | 4 days ago 81% | 4 days ago 77% |
| TrendMonth ODDS (%) | 4 days ago 79% | 4 days ago 82% |
| Advances ODDS (%) | 7 days ago 82% | 13 days ago 76% |
| Declines ODDS (%) | N/A | 6 days ago 66% |
| BollingerBands ODDS (%) | 4 days ago 84% | 4 days ago 55% |
| Aroon ODDS (%) | 4 days ago 83% | 4 days ago 64% |
A.I.dvisor tells us that FGM and CBK have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FGM and CBK's prices will move in lockstep.